Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2026-06-02 @ 12:00 AM
Study NCT ID:
NCT05094804
Status:
UNKNOWN
Last Update Posted:
2023-11-02
First Post:
2021-09-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Sponsor:
OncoResponse, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
| None | Tumor, Solid | View |
| None | Malignant Neoplasm | View |
| None | Metastatic Cancer | View |
| None | Advanced Solid Tumor | View |
| None | Non Small Cell Lung Cancer | View |
| None | Melanoma | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Leiomyosarcoma | View |
| None | Liposarcoma | View |
Keywords: